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BACKGROUND: The association between maternal infection and neurodevelopmental defects in progeny is well
established, although the biological mechanisms and the pathogenic trajectories involved have not been deﬁned.
METHODS: Pregnant dams were injected intraperitoneally at gestational day 9 with polyinosinic:polycytidylic acid.
Neuronal development was assessed by means of electrophysiological, optical, and biochemical analyses.
RESULTS: Prenatal exposure to polyinosinic:polycytidylic acid causes an imbalanced expression of the Na1-K1-
2Cl2 cotransporter 1 and the K1-Cl2 cotransporter 2 (KCC2). This results in delayed gamma-aminobutyric acid
switch and higher susceptibility to seizures, which endures up to adulthood. Chromatin immunoprecipitation
experiments reveal increased binding of the repressor factor RE1-silencing transcription (also known as neuron-
restrictive silencer factor) to position 509 of the KCC2 promoter that leads to downregulation of KCC2
transcription in prenatally exposed offspring. Interleukin-1 receptor type I knockout mice, which display braked
immune response and no brain cytokine elevation upon maternal immune activation, do not display KCC2/Na1-
K1-2Cl2 cotransporter 1 imbalance when implanted in a wild-type dam and prenatally exposed. Notably,
pretreatment of pregnant dams with magnesium sulfate is sufﬁcient to prevent the early inﬂammatory state and
the delay in excitatory-to-inhibitory switch associated to maternal immune activation.
CONCLUSIONS: We provide evidence that maternal immune activation hits a key neurodevelopmental process, the
excitatory-to-inhibitory gamma-aminobutyric acid switch; defects in this switch have been unequivocally linked to
diseases such as autism spectrum disorder or epilepsy. These data open the avenue for a safe pharmacological
treatment that may prevent the neurodevelopmental defects caused by prenatal immune activation in a speciﬁc
pregnancy time window.
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https://doi.org/10.1016/j.biopsych.2017.09.030Disruption of correct neurodevelopmental trajectories by
maternal immune activation (MIA) is a critical factor in the
development of neurological and neuropsychiatric disorders
(1–3), especially when maternal infections synergize with a
susceptible genetic background or when the prenatal event is
followed by postnatal risk factors that act as “second hits” (3,4).
In recent years, the consequences of maternal infections on
offspring brain have been explored using mouse models based
on prenatal exposure to immune stimuli (5–9). The immuno-
gens most commonly used in rodent models have been lipo-
polysaccharide, a component of the cell wall of gram-negative
bacteria that binds to toll-like receptor 4 and mimics bacterial
infection, or polyinosinic:polycytidylic acid (PolyI:C), a double-
stranded, synthetic RNA that binds to toll-like receptor 3 like
viral nucleic acid. Injection of either immunogen initiates a
signaling cascade that leads to the production of inﬂammatoryª 2017 Society of Biological Psychiatry. This is an open access ar
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc
ical Psychiatry April 15, 2018; 83:680–691 www.sobp.org/journalmediators, such as chemokines, cytokines, and complement
proteins (10).
Consistent with epidemiological data, preclinical studies in
these models have shown a wide spectrum of long-term
behavioral changes, including impaired sensorimotor gating
(prepulse inhibition) (8,11,12), increased anxiety-like behavior
(13), cognitive deﬁcits (12,14), and altered exploratory behavior
(6,12). The phenotypic abnormalities in offspring are frequently
accompanied by brain alterations, although with a high degree
of variability depending on the speciﬁc immune activation
paradigm (7,15,16). Injecting the immunogen at different time
points during gestation leads to different neuropathological
features (6), gene expression proﬁles (7), and behavioral
abnormalities in offspring (6).
Although epidemiological and preclinical evidence indicate
that intrauterine exposures elicit enduring effects on offspring,ticle under the
-nd/4.0/).
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Figure 1. Maternal immune activation results in altered network activity and increased offspring susceptibility to seizures in the absence of synaptic
modiﬁcations. (A) (Left) Evaluation of the behavioral response of control (Ctrl) mice and mice that were prenatally treated with polyinosinic:polycytidylic acid
(PolyI:C) to 35 mg/kg kainic acid systemic injection. All mice were scored every 10 minutes over a 3-hour period. In all mice, kainate injection resulted in
immobility and staring during the ﬁrst 10 minutes. PolyI:C mice showed clear signs of focal epilepsy (head bobbing), culminating in continuous generalized
seizures (stage 5, status epilepticus) that lasted for about 80 minutes. Two-way analysis of variance followed by Sidak’s multiple comparisons test, *p , .05,
***p , .001, ****p , .0001. (Right) Quantitative analysis of the mean score variation at 180 minutes. Student’s t test, ***p , .001. Numbers in bars indicate the
number of animals. (B) (Left) Representative electrophysiological traces of cell-attached recording in acute cortical slices at postnatal day 20 established from
PolyI:C and Ctrl mice. (Right) Quantitative analysis of the spiking activity. Bars represent mean 6 SEM (Ctrl = 0.09 6 0.06, PolyI:C = 0.75 6 0.24). Mann-
Whitney U test, *p , .05. Numbers in bars indicate the number of cells/animals. (C) (Left) Representative traces of excitatory and inhibitory miniature post-
synaptic currents recorded from postnatal day 20 cortical slices obtained from PolyI:C prenatally treated mice (lower traces) and Ctrl mice (upper traces).
(Right) Electrophysiological analysis of the frequency and the amplitude of miniature excitatory postsynaptic currents (mEPSCs) and miniature inhibitory
postsynaptic currents (mIPSCs). Bars represent mean 6 SEM (mEPSC frequency: Ctrl = 3.99 6 0.27, PolyI:C = 4.01 6 0.22; mIPSC frequency: Ctrl = 3.20 6
0.27, PolyI:C = 3.13 6 0.32; mEPSC amplitude: Ctrl = 17.57 6 2.26, PolyI:C = 20.29 6 1.98; mIPSC amplitude: Ctrl = 22.33 6 1.14, PolyI:C = 24.33 6 1.54).
Student’s t test. Numbers in bars indicate the number of cells/animals. ns, not signiﬁcant.
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Psychiatrythe speciﬁc molecular targets and the pathogenic pathways
involved in brain alterations after prenatal immune activation
are still far from elucidated. Recent studies investigated
possible alterations in offspring brain transcriptome or prote-
ome, in the attempt to identify mechanisms at the basis of
postnatal changes induced by MIA: a widespread dysregula-
tion has been unveiled in several genes linked to neuronal
development, mitochondrial function, synaptic vesicle recy-
cling, cytoskeletal structures, energy metabolism, and signal
transduction (17,18). However, the possible functional impact
of these transcriptomic or proteomic changes is still unknown.
In this framework, we aimed to assess whether prenatal
immune activation impacts synapse formation and function,
and whether it affects the excitatory versus inhibitory balance
in neurotransmission, which is one common trait shared by
different neurodevelopmental diseases.
METHODS AND MATERIALS
Animals
All experiments followed the guidelines established by the
European Directive 2010/63/EU and the Italian Governing LawBiological26/2014. Dams were injected with PolyI:C (Sigma-Aldrich,
St. Louis, MO) or vehicle intraperitoneally on gestational day 9
(GD9). For the embryo transfer procedure, embryos from
interleukin-1 receptor type I knockout (IL-1RI KO) female mice
were implanted into wild-type (WT) pseudopregnant female
mice, following standard techniques (19). The magnesium
treatment protocol was adapted from Hallak et al. (20). Kainate
treatment was performed as previously described (21), and
seizure severitywasdeterminedaccording toRacine’sscale (22).
Cell Cultures
Cortical neurons were established from C57BL/6 mice at
embryonic day 18 (E18) from vehicle or PolyI:C-treated
mothers as previously described (23,24).
Imaging and Electrophysiology
Calcium imaging was performed on cortical cultures as pre-
viously described (25,26).
Cultured cortical neurons were recorded at 14 days in vitro
(DIV) using an Axopatch 200B ampliﬁer with a Digidata 1440
digitizer (Axon Instruments, Foster City, CA). Whole cell re-
cordings were performed as previously reported (25).Psychiatry April 15, 2018; 83:680–691 www.sobp.org/journal 681
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PsychiatryElectrophysiological recording from brain slices was performed
as described by Lien et al. (27).
Biochemistry
Western blot analysis was performed on cortical tissues from
E17, postnatal day 20 (P20), and P90 PolyI:C or vehicle pre-
natally treated mice and on 7 DIV cortical neurons.
Chromatin Immunoprecipitation and Real-time
Polymerase Chain Reaction
Immunoprecipitation was performed on cortical tissue from P20
mice incubated with protein G Dynabeads (Invitrogen Corpora-
tion, Carlsbad, CA) bound to RE1-silencing transcription factor
(REST) (Millipore, Burlington, MA) or methyl-CpG-binding pro-
tein 2 (Sigma-Aldrich) polyclonal antibody;K1-Cl2 cotransporter
2 (KCC2) promoter was then analyzed by quantitative real-time
polymerase chain reaction (PCR). For total RNA analysis, real-
time PCR was performed on embryonic or P20 tissues.
Statistics
The results are presented as mean 6 SEM. Student’s two-
tailed paired or unpaired t tests and one- or two-way anal-
ysis of variance, followed by Tukey’s or Sidak’s multiple
comparisons test, were used for normal distributions. The
Mann-Whitney nonparametric U test was used for non-
normally distributed data.
Details can be found in the Supplement.
RESULTS
PolyI:C Mice Show Increased Susceptibility to
Epilepsy in the Absence of Chronic Inﬂammation or
Synaptic Alterations
A single PolyI:C exposure performed at GD9 (i.e., at the
beginning of cortical neuronal layering) was sufﬁcient to
increase offspring susceptibility to seizures at 3 months of age.
Response to intraperitoneal administration of 35 mg/kg kainic=
Figure 2. Polyinosinic:polycytidylic acid (PolyI:C) delays the excitatory-to-inhib
RE1-silencing transcription factor (REST) (also known as neuron-restrictive silence
transcription. (A) (Left) Representative traces of spontaneous spiking activity reco
and control (Ctrl) mice before and after puff application of 200 mM GABA. (Right) Q
application. Paired t test, *p , .05. Numbers in brackets indicate the number of
upon application of 10 mM bumetanide showed a signiﬁcant reduction of spike fre
the number of cells/animals. (C) (Left) Representative images of two-photon ima
neurons loaded with the chloride-sensitive dye N-(ethoxycarbonylmethyl)-6-meth
rescence lifetime imaging microscopy value of the dye. (Right) Cumulative probab
PolyI:C and Ctrl cortical neurons show a signiﬁcantly higher fraction of neurons dis
Bars represent mean 6 SEM (Ctrl = 4.24 6 0.18, PolyI:C = 3.51 6 0.12). Student’s
bar = 20 mm). (D) Stern–Volmer plot of MQAE quenching at a given Cl– concentra
slope of the regression line gives a Stern–Volmer constant of 31M–1. (E) Repres
expression at different ages in cortices from PolyI:C and Ctrl offspring. (Bottom) KC
homogenates from mice prenatally treated with PolyI:C compared with Ctrls, whil
increased in embryonic day 17 (E17) and P20 cortical homogenates from PolyI:C
levels were normalized on either calnexin or tubulin. Student’s t test, *p, .05. Num
reaction analysis for ion cotransporters KCC2 and NKCC1 performed in P20
messenger RNA levels was detected for KCC2 but not for NKCC1. (G) (Top) Map o
for REST and methyl-CpG-binding protein 2 (MeCP2) binding to the Kcc2 promot
509. N.D., not detectable; ns, not signiﬁcant; TSS, transcription start site.
Biologicalacid (KA) was compared in offspring of mothers exposed to
PolyI:C versus vehicle (control), by behavioral evaluation
repeated every 10 minutes over a 3-hour period (Figure 1A). In
all mice, KA resulted in immobility and staring followed by head
bobbing and isolated limbic motor seizures (Racine scale,
stage 4), characterized by forelimb clonus and rearing. While
control mice only displayed isolated limbic motor seizures,
PolyI:C mice rapidly progressed to stage 5 (status epilepticus)
and showed continuous generalized activity lasting for about
80 minutes (Figure 1A, left). One hundred eighty minutes after
KA injection, PolyI:C mice still displayed a signiﬁcantly higher
mean Racine score relative to control mice (Figure 1A, right).
PolyI:C mice did not display seizures either during normal
activity or upon manipulation at any age; seizures were only
evident after KA treatment. Contrary to prenatal exposure to
the inﬂammatory hit, adult exposure did not result in any long-
lasting increase of circuit hyperactivity. Indeed, a single PolyI:C
treatment in adult mice failed to increase susceptibility to
seizures (Supplemental Figure S1B). In line with the higher
susceptibility to seizures, layer 5 neurons recorded by cell-
attached patch clamp in acute cortical slices of PolyI:C-
exposed progeny displayed a higher spike frequency than
controls (Figure 1B).
Epilepsy may be the consequence of inﬂammatory pro-
cesses (28), and therefore we investigated whether the hy-
peractivity and increased susceptibility to epilepsy observed in
mice that were prenatally exposed to PolyI:C was associated
with enhanced brain inﬂammation. Brains of 3-month-old mice
that were prenatally exposed to either PolyI:C or vehicle were
examined by confocal microscopy; the number and morpho-
logical appearance of microglial cells and the expression of
proinﬂammatory markers were quantiﬁed. No differences
were observed between PolyI:C and control mice, either in
the number of microglia—revealed by the speciﬁc marker
Iba1 (Supplemental Figure S2A)—or in the expression of
CD11b (Supplemental Figure S2A) or glial ﬁbrillary acidic pro-
tein (Supplemental Figure S2C). Unlike activated microglia,
which are known to retract their branches and assume anitory gamma-aminobutyric acid (GABA) switch by increasing repressor factor
r factor) binding to K1-Cl2 cotransporter 2 (KCC2) promoter and reducing its
rded in cell-attached patch-clamp conﬁguration in acute slices from PolyI:C
uantitative analysis of the spontaneous activity in cortical slices upon GABA
cells/animals. (B) Quantitative analysis of neuronal activity in cortical slices
quency in PolyI:C slices. Paired t test, *p, .05. Numbers in brackets indicate
ging of ﬂuorescence lifetime imaging microscopy values of [Cl–]i in cortical
oxyquinolinium bromide (MQAE). [Cl–]i is inversely proportional to the ﬂuo-
ility and quantitative analysis of ﬂuorescence lifetime imaging microscopy in
playing increased [Cl–]i in PolyI:C cortical slice neurons compared with Ctrls.
t test, **p, .01. Numbers in bars indicate the number of cells/animals (scale
tion allows for the determination of intracellular chloride concentration. The
entative Western blot lanes and biochemical analyses of ion cotransporter
C2 protein levels are signiﬁcantly reduced in postnatal day 20 (P20) and P90
e Na1-K1-2Cl2 cotransporter 1 (NKCC1) protein levels (top) are signiﬁcantly
mice compared with Ctrls and return to Ctrl levels in P90 cortices. Protein
bers in bars indicate the number of animals. (F) Real-time polymerase chain
brains of PolyI:C- and vehicle-treated offspring. A signiﬁcant reduction of
f the mouse Kcc2 promoter. (Bottom) Chromatin immunoprecipitation assay
er showing an increased binding of both the transcription factors to position
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Figure 3. Primary hippocampal neurons from polyinosinic:polycytidylic acid (PolyI:C)–exposed embryos display altered burst activity. (A) (Left) Repre-
sentative traces of cell-attached recording of spontaneous activity in control and PolyI:C–cultured neurons. (Right) Quantitative analysis of spontaneous
activity shows a higher neuronal activity in 14 days in vitro (DIV) PolyI:C cultures compared with controls (Ctrls). Bars represent mean 6 SEM (Ctrl = 0.98 6
0.08, PolyI:C = 1.97 6 0.37). Student’s t test, **p , .01. Numbers in bars indicate the number of cells. (B) (Left) Representative traces of bursts of action
potentials in PolyI:C and Ctrl cultured neurons. (Right) Quantitative analysis of the burst activity recorded in 14 DIV primary cortical neurons showing a higher
frequency of long bursts of action potentials in PolyI:C cultures. Bars represent mean 6 SEM (Ctrl = 0.94 6 0.07, PolyI:C = 1.60 6 0.13). Student’s t test, **p ,
.01. Numbers in bars indicate the number of cells. (C) (Top) Representative immunoﬂuorescence images obtained from 14 DIV primary cortical cultures
established from embryos at embryonic day 18 that were prenatally treated with PolyI:C or vehicle showing the presynaptic excitatory marker vesicular
glutamate transporter 1 (vGlut1) (in blue) and the presynaptic inhibitory marker vesicular gamma-aminobutyric acid transporter (vGAT) (in red) (scale bar = 5
mm). (Bottom) Quantitative analysis of the number of positive vGlut1/vGlut2 and vGAT puncta over the total number of vGlut1 1 vGAT or vGlut2 1 vGAT
positive puncta showing no differences between the two experimental groups. Student’s t test. Numbers in bars indicate the number of analyzed ﬁelds. (D)
(Left) Representative traces of miniature excitatory postsynaptic currents (mEPSCs) and miniature inhibitory postsynaptic currents (mIPSCs) recorded in 14 DIV
primary cortical neurons from prenatally treated embryos (PolyI:C or Ctrls). (Right) Electrophysiological analysis of the frequency and the amplitude of EPSCs
and IPSCs showing no differences between the two experimental groups. Bars represent mean 6 SEM (mEPSC frequency: Ctrl = 1.03 6 0.12, PolyI:C =
1.09 6 0.17; mEPSC amplitude: Ctrl = 17.92 6 1.99, PolyI:C = 17.17 6 1.74; mIPSC frequency: Ctrl = 1.00 6 0.17, PolyI:C = 1.08 6 0.20; mIPSC amplitude:
Ctrl = 15.69 6 0.73, PolyI:C = 17.31 6 0.84). Student’s t test. Numbers in bars indicate the number of cells. ns, not signiﬁcant.
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Psychiatryamoeboid appearance (29,30), in prenatally exposed brains,
microglia displayed ramiﬁcations of comparable length,
although slightly reduced in number, compared with controls
(Supplemental Figure S2B). Also, the levels of cytokines IL-1b,
IL-6, and tumor necrosis factor alpha, analyzed by real-time
PCR, were under detection levels (not shown).
Seizures may also be the result of a change in the excit-
atory/inhibitory balance (31). We therefore investigated
whether prenatal immune challenge altered glutamatergic or
gamma-aminobutyric acidergic (GABAergic) synaptic trans-
mission in the adult offspring. No differences were observed in
either glutamatergic or GABAergic spontaneous synaptic cur-
rents in patch clamp recordings from P20 acute cortical slices684 Biological Psychiatry April 15, 2018; 83:680–691 www.sobp.org/jofrom PolyI:C- or vehicle-exposed offspring: the frequency and
amplitude of miniature excitatory postsynaptic currents and
miniature inhibitory postsynaptic currents were comparable
(Figure 1C). Consistently, Western blot analysis of E17 and P90
cortices from PolyI:C or control mice revealed no differences in
the expression of synaptic markers, including the vesicular
glutamate transporters vGlut1 and vGlut2, the GABA vesicular
transporter vGAT, and the two soluble N-ethylmaleimide-sen-
sitive factor attachment protein receptors SNAP-25 and syn-
taxin 1A (Supplemental Figure S3). These data indicate that the
increased susceptibility to seizures of PolyI:C offspring is un-
likely to result from imbalance in the relative number of excit-
atory or inhibitory synapses.urnal
Figure 4. Primary hippocampal neurons from
polyinosinic:polycytidylic acid (PolyI:C)–exposed
embryos display altered excitatory-to-inhibitory
switch. (A) (Left) Representative ﬂuorescence im-
ages of 6 days in vitro cortical neurons loaded with
the calcium dye Fura2 in basal state (left) and upon
gamma-aminobutyric acid (GABA) (center) and
KCl (right) stimulation; also shown are the temporal
analyses of the respective calcium changes. White
arrows indicate GABA-responding neurons. The
quantitative analysis (right panels) shows a higher
percentage of GABA-responding neurons in PolyI:C
compared to control (Ctrl) cultures (top), whereas the
magnitude of the GABA-induced calcium response
was unchanged in the two conditions (bottom). Bars
represent mean 6 SEM (% of GABA-responding
neurons: Ctrl = 1.00 6 0.11, PolyI:C = 1.43 6 0.14;
GABA-inducedcalcium response [DF/F0]:Ctrl = 0.996
0.04, PolyI:C = 0.95 6 0.03). Student’s t test, *p , .05
(scale bar = 40 mm). (B) (Left) Bright-ﬁeld (left
panels) and pseudocolor (right panels) images of
N-(ethoxycarbonylmethyl)-6-methoxyquinolinium bro-
mide (MQAE)–loaded neurons in the two experimental
conditions. (Right) Cumulative probability and quanti-
tative analysis of MQAE ﬂuorescence indicate a
signiﬁcantly lower fraction of low-[Cl–]i (high MQAE)
cortical neurons in PolyI:C compared with Ctrls. Bars
represent mean6 SEM (Ctrl = 324.36 2.54, PolyI:C =
297.2 6 1.65). Mann-Whitney U test, ****p , .0001.
Numbers in bars indicate the number of cells/animals.
(C) K1-Cl2 cotransporter 2 (KCC2) and Na1-K1-2Cl2
cotransporter 1 (NKCC1) expression pattern in 6 days
in vitro cortical cultures established from control and
PolyI:C embryos. Student’s t test, *p, .05. Numbers in
bars indicate the number of embryos. ns, not
signiﬁcant.
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Excitatory-to-Inhibitory Switch and Altered KCC2/
NKCC1 Expression in PolyI:C Mice
A hyperactivity of neuronal networks may also result from a
reduced inhibitory action of GABA, a phenomenon that might
be linked to an altered excitatory-to-inhibitory switch. The
latter process, which consists in the transition of GABA
signaling from depolarizing to hyperpolarizing, starts soon after
birth and is complete in rodents by the end of the ﬁrst postnatal
week. Defects in excitatory-to-inhibitory switch may lead to an
excitatory/inhibitory imbalance (32,33). To assess whether the
process of excitatory-to-inhibitory switch was correctly
completed in PolyI:C cortical circuits, neurons were stimulated
with a puff of 200-mM GABA, and spontaneous activity was
recorded in cell-attached conﬁguration. In contrast to control
brain slices, where neuronal activity was slightly reduced by
GABA application, GABA signiﬁcantly increased the neuronal
ﬁring rate in PolyI:C slices (Figure 2A), indicating that the
neurotransmitter still exerts an excitatory action in PolyI:C
offspring. The resting potential of neurons was –65.88 6 1.43
mV (n = 8) in control and –67.30 6 1.36 mV (n = 10) in PolyI:CBiologicalslices (unpaired t test, p = .48). Of note, application of the
Na1-K1-2Cl2 cotransporter 1 (NKCC1) antagonist bumetanide
(10 mM) resulted in a signiﬁcant reduction of spike frequency in
PolyI:C slices (Figure 2B).
The excitatory action of GABA at early stages of neuronal
development results from high intracellular chloride concentra-
tions, which determine a more positive equilibrium potential for
chloride and depolarizing chloride currents through GABAA
receptors (34). In order to unequivocally demonstrate the
occurrence of an altered excitatory-to-inhibitory switch in
PolyI:Cmousebrains,wedirectlymonitored intracellular chloride
levels ([Cl–]i) by means of ﬂuorescence lifetime imaging micro-
scopy of the chloride-sensitive dye N-(ethoxycarbonylmethyl)-
6-methoxyquinolinium bromide (MQAE) in P20 brain slices. As
expected, PolyI:C cortical slices showed a higher resting [Cl–]i
(revealed by a decrease in the ﬂuorescence lifetime) compared
with control mice (Figure 2C), indicating a delay in excitatory-
to-inhibitory switch. Calibration measurement of MQAE lifetime
with known intracellular chloride concentrations revealed a
Stern–Volmer constant of 31 M–1 (Figure 2D). In the calibration
experiments, control brain slicesMQAE lifetimecorresponded toPsychiatry April 15, 2018; 83:680–691 www.sobp.org/journal 685
Figure 5. Magnesium sulfate prevents cytokine elevation in the embryos and reverts polyinosinic:polycytidylic acid (PolyI:C)–induced alterations.
(A) Cytokine messenger RNA (mRNA) levels of interleukin-1b (IL-1b) and IL-6 in the embryos 3, 6, and 24 hours after vehicle or PolyI:C injection in the mother.
Student’s t test, *p , .05, ***p , .001. Numbers in bars indicate the number of embryos. (B) Transforming growth factor-b (TGFb1) and IL-17a in control (Ctrl)
and PolyI:C prenatally treated embryos 6 hours after the injection in the mother. Numbers in bars indicate the number of embryos. (C) Embryonic mRNA levels
of IL-1b and IL-6 six hours after the injection in interleukin-1 receptor type I knockout (IL-1RI KO) mothers showing no increase in cytokine mRNA upon PolyI:C
administration. Numbers indicate the number of animals. (D) (Left) Schematic representation of embryo transfer procedure. (Right) Biochemical analysis of ion
cotransporter K1-Cl2 cotransporter 2 (KCC2) in Ctrls, embryo transfer procedure (ETP) offspring treated with PolyI:C, and naïve IL-1RI KO offspring at
postnatal day 90 (P90) showing no increase in KCC2 expression in embryo transfer procedure offspring upon PolyI:C administration. Unchallenged IL-1RI KO
mice were found to display higher, although not signiﬁcantly, expression of KCC2. Numbers indicate the number of animals. (E) (Left) Scheme of primary
neuronal cultures treatment with IL-1b alone (40 ng/mL) or in combination with IL-6 (10 ng/mL). (Right) Cortical neurons at 6 days in vitro (DIV) treated at 1 DIV
with IL-1b alone or with IL-1b and IL-6 together display higher intracellular chloride levels as detected by N-(ethoxycarbonylmethyl)-6-methoxyquinolinium
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Psychiatryan intracellular chloride concentration of 9.55mM. Based on this
estimate, chloride concentration in control brain slices turned
out to be 9.5 6 1.40 mM, whereas neurons in PolyI:C-treated
slices displayed an intracellular chloride concentration of 15.46
1.25mM.Considering the extracellular concentration of chloride
(139.2mM), these values correspond to equilibrium potentials of
–67.1 or –55.7 mV, for control and PolyI:C, respectively, and to
driving forces for chloride ions of –1.1 and 10.2, respectively.
Chloride homeostasis in neurons is controlled through the
developmentally regulated expression of NKCC1 (Cl2 importer)
and KCC2 (Cl2 exporter) that undergo, respectively, a reduction
(NKCC1) and a parallel increase (KCC2) during development,
resulting in the switch from depolarizing to hyperpolarizing
GABAA activation during neuronal maturation (32,33,35).
Consistent with functional data, Western blotting analysis in
homogenates fromE17 andP20 cortices revealed a signiﬁcantly
higher expression of NKCC1 in PolyI:C versus control brains,
which returned to control levels in adult P90 mice (Figure 2E).
Conversely, both P20 and P90 PolyI:C cortices displayed a
signiﬁcantly lower KCC2 amount (Figure 2E). Therefore, a single
challenge of the maternal immune system at GD9 delays the
reciprocal changes in the expression of NKCC1 and KCC2,
leading to higher intracellular chloride concentrations and
delaying the disappearance of GABA excitatory activity.
The Neuronal Gene Repressor REST Displays
Enhanced Binding to the KCC2 Promoter in PolyI:C
Prenatally Exposed Mice
Real-time PCR was performed in P20 brains of PolyI:C- and
vehicle-treated offspring (Figure 2A–C) to assess whether
changes in mRNA levels accompanied the altered expression
of KCC2 and NKCC1 observed at P20, the time point when
our electrophysiological, ﬂuorescence lifetime imaging
microscopy–based, and Western blot experiments were per-
formed. At difference with the decreased KCC2 and increased
NKCC1 expression (Figure 2E), a change in relative mRNA
levels was evident for KCC2 only (Figure 2F). Chromatin
immunoprecipitation experiments were performed to get further
insight into the processes responsible for reduced Kcc2 tran-
scription: we found increased binding of both REST (also known
as neuron-restrictive silencer factor) and methyl-CpG-binding
protein 2, which are known to repress Kcc2 transcription (36),
to position 509 of the Kcc2 promoter (Figure 2G). These data
indicate that prenatal PolyI:C activates epigenetic changes
leading to the downregulation of Kcc2 transcription and=
bromide (MQAE) ﬂuorescence intensity reduction. One-way analysis of variance (A
Numbers indicate the number of cells/animals. (F) Quantitative analysis of IL-6 pla
magnesium sulfate (MgSO4) treatment before PolyI:C. MgSO4 is able to prevent
one-way ANOVA followed by Tukey’s multiple comparisons test, ***p, .001. Num
and IL-6 mRNA levels in whole embryos 6 hours after vehicle, PolyI:C alone, or Mg
in IL-1b and IL-6 mRNA levels observed in the PolyI:C embryos. One-way ANOV
***p , .001. Numbers in bars indicate the number of embryos. (H) KCC2 protein
MgSO4 is administered before PolyI:C to the mother. Student’s t test. Numbers in
chloride from ﬂuorescence lifetime values measured by two-photon imaging in P2
prenatally treated with PolyI:C alone. Bars represent mean 6 SEM (Ctrl = 4.32
ANOVA followed by Tukey’s multiple comparisons test, *p , .05, **p , .001. (J
in Ctrl, PolyI:C, and MgSO4 1 PolyI:C offspring. Notably, MgSO4 is able to prev
PolyI:C. One-way ANOVA followed by Sidak’s multiple comparisons test, *p , .0
####p , .0001 (PolyI:C vs. MgSO4 1 PolyI:C). Numbers in brackets indicate the
Biologicalsuggest that some posttranslational mechanisms may be
responsible for the higher NKCC1 expression level.
PolyI:C-Induced Alterations Are Recapitulated in
Neuronal Cultures
Our next goal was to investigate whether the altered
excitatory-to-inhibitory switch promoted by maternal immune
activation is a process intrinsically maintained in neurons
independently from the brain environment. To speciﬁcally
address this point, we established primary cultures of cortical
neurons from embryos at E18 that were exposed to PolyI:C or
vehicle at GD9. This selective analysis of neurons would rule
out the possible contributions of other non-neuronal cell types.
Spiking activity was assessed by multiunit recording, which
reﬂects action potential ﬁring in the cell attached mode (37). In
line with ex vivo data, spontaneous spiking activity was
signiﬁcantly higher in PolyI:C neuronal cultures compared with
controls (Figure 3A); spontaneous burst activity (38), which
represents spontaneous paroxysmal depolarizing shifts due to
synchronous neuronal ﬁring (39,40), was also enhanced
(Figure 3B). This occurred in the absence of changes in the
density of vGlut1- or vGlut2-positive glutamatergic terminals or
of vGAT-positive GABAergic terminals (Figure 3C); the fre-
quency or amplitude of spontaneous miniature excitatory or
miniature inhibitory postsynaptic currents (Figure 3D) were
also unchanged, in line with the ex vivo experiments. The
resting potential was –51.6 6 0.99 mV (n = 17) in control and
52.2 6 1.21 mV (n = 18) in PolyI:C-cultured neurons (unpaired
t test, p = .70).
In line with GABA displaying depolarizing activity, cultures
established from the brains of prenatally exposed offspring
exhibited a higher percentage of neurons responding to GABA
application with intracellular calcium elevations, as assessed
by single-cell calcium imaging of cortical neurons loaded with
the ﬂuorescent dye Fura-2. The magnitudes of the calcium
responses induced by GABA were not changed (Figure 4A). In
agreement with the higher percentage of neurons responding
to GABA (49% vs. 35%), the cumulative distribution of MQAE
ﬂuorescence intensity in PolyI:C versus control neuronal cul-
tures revealed a higher average intracellular chloride level in
PolyI:C neurons (Figure 4B). In particular, the percentages of
neurons with MQAE readings ,290 (high intracellular chloride)
were about 49% for PolyI:C versus 35% for saline (consistent
with the percentages of GABA-responding neurons); MQAE
readings in these subpopulations were similarly distributed,NOVA) followed by Tukey’s multiple comparisons test, *p , .05, ***p, .001.
smatic levels in adult female mice 3 hours after PolyI:C injection alone or with
the increase in IL-6 plasma levels observed with the PolyI:C alone. Ordinary
bers in bars indicate the number of animals. (G) Quantitative analysis of IL-1b
SO41 PolyI:C injection in the mother. MgSO4 is able to prevent the increase
A followed by Tukey’s multiple comparisons test, *p , .05, **p , .01, and
levels in P90 offspring are not affected by PolyI:C prenatal treatment when
bars indicate the number of animals. (I) Quantitative analysis of intracellular
0 brain slices. MgSO4 can prevent the increase in [Cl
–]i observed in offspring
6 0.14, PolyI:C = 3.61 6 0.10, MgSO4 1 PolyI:C = 4.87 6 0.23). One-way
) Time course of the behavioral response to 35 mg/kg kainic acid injection
ent increased seizure susceptibility when administered in the mother before
5, **p , .01, ***p , .001 (Ctrl vs. PolyI:C), #p , .05, ##p , .01, ###p , .001,
number of animals. NS, not signiﬁcant; WT, wild-type.
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similar distribution of intracellular chloride concentration;
therefore, the similarly sized calcium responses to GABA were
not unexpected. The change produced by PolyI:C in the
expression pattern of the chloride cotransporters, KCC2 and
NKCC1, was conﬁrmed in cultured neurons: in 7 DIV PolyI:C
cultures, neurons displayed lower levels of KCC2 and higher
levels of NKCC1 (Figure 4C). These data indicate that the
molecular consequences of an early immune challenge remain
“sculpted” in the developmental program of neurons even
when they are isolated from the brain environment.
Reducing Cytokine Elevation in the Embryo Is
Sufﬁcient to Avoid KCC2 Dysregulation
PolyI:C treatment, administered at GD9, is known to signiﬁ-
cantly increase IL-6 levels in the plasma of injected dams
compared to vehicle treatment (6) (Supplemental Figure S1A).
Of note, embryos from immune-challenged dams displayed a
transient increase in the mRNA levels for the proinﬂammatory
cytokines IL-1b and IL-6, which rose 6 hours after PolyI:C
injection and returned to basal levels 24 hours after stimulation
(Figure 5A). No differences were detected in the mRNA levels
for transforming growth factor-b and IL-17a (Figure 5B).
To investigate whether the cytokine storm occurring in the
offspring 6 hours after the dam challenge with PolyI:C could be
at the origin of the dysregulation in transporter expression and
in chloride homeostasis, we took advantage of IL-1RI KO mice,
in which the immune response is subjected to a brake that
tunes down the inﬂammatory process (41). As expected,
differently from WT mice, PolyI:C injection in IL-1RI KO preg-
nant dams did not result in any elevation of IL-1b or IL-6 in the
embryos (Figure 5C). To unequivocally dissect the contribution
of the embryonic cytokines to the process, we performed an
embryo transfer procedure: IL-1RI KO embryos were implanted
in WT mothers, which would respond normally to PolyI:C
treatment, the offspring alone being impaired in the immune
activation process (Figure 5D, left). KCC2 expression levels
were quantiﬁed at P90, when a high (around 30%) reduction of
the transporter expression occurs in prenatally exposed WT
mice (Figure 5D, right), and no changes of KCC2 were detec-
ted in the IL-1RI KO embryo transfer procedure offspring. Of
note, unchallenged IL-1RI KO mice displayed higher expres-
sion of KCC2, suggesting an endogenous role of the immune
response in controlling KCC2 expression, even under physio-
logical conditions. In line with the role of cytokines in regulating
neuronal developmental processes involved in chloride
homeostasis, MQAE ﬂuorescence intensity measurements
indicated a higher intracellular chloride concentration in pri-
mary cortical neurons exposed to either a combination of IL-1b
(40 ng/mL) and IL-6 (10 ng/mL) or to IL-1b alone (40 ng/mL) at
1 DIV and recorded at 6 DIV (Figure 5E).
Magnesium Sulfate Rescues PolyI:C-Induced
Alterations
Given our demonstration that preventing cytokine elevation in
the offspring brain is sufﬁcient to prevent the subsequent
reduction of KCC2 expression, we reasoned that pharmaco-
logical impairment of such increase could represent a good
strategy to avoid possible neurodevelopmental defects after688 Biological Psychiatry April 15, 2018; 83:680–691 www.sobp.org/joMIA. It has been reported that magnesium acts as an immu-
nomodulator that is able to decrease inﬂammatory cytokine
production (42). Of note, magnesium is already used to reduce
inﬂammation at the maternal–fetal interface (43). We therefore
investigated whether dam treatment with magnesium sulfate
(MgSO4) before PolyI:C injection (see Methods and Materials
for details) prevented the increase of the proinﬂammatory
cytokines. As expected, pretreated dams did not display ele-
vations of IL-6 upon PolyI:C injection (Figure 5F). Accordingly,
mRNA levels for IL-6 or IL-1b did not undergo any increase in
embryos from MgSO4-pretreated dams (Figure 5G). Consistent
with our demonstration that preventing the cytokine elevations
in the embryos is sufﬁcient to prevent the transporter dysre-
gulation, KCC2 expression was unaltered in the offspring of
PolyI:C dams pretreated with MgSO4 (Figure 5H). Consistently,
the ﬂuorescence lifetime imaging microscopy experiment indi-
cated that intracellular chloride levels in P20 brain slices were
comparable to those of vehicle-exposed offspring (Figure 5I;
chloride concentration was estimated to 7.7 6 1.16 mM in
MgSO4-pretreated PolyI:C animal slices vs. 9.5 6 0.87 mM in
control brain slices) and, even more importantly, the increased
susceptibility to seizures was fully prevented (Figure 5J). These
data indicate that MgSO4 in the embryos can abolish the
PolyI:C-dependent increase in proinﬂammatory cytokines and
the long-lasting effects associated with MIA.DISCUSSION
The use of mouse models based on prenatal immune activa-
tion allows for monitoring the impact of the challenge during
development and is essential for determining the molecular
pathways that mediate the resulting neuropathology (5,7,9). As
underlined by Estes and McAllister (4), rodent models of MIA
meet all the criteria for a valid disease model because they
efﬁciently mimic a known disease-related risk factor (construct
validity), exhibit a range of disease-related symptoms (face
validity), and are effectively used to predict the efﬁcacy of
treatments (predictive validity). Despite these advantages, in
most cases the mechanistic basis remains elusive.
Our study provides the demonstration that a single intra-
uterine exposure at GD9 signiﬁcantly increases offspring sus-
ceptibility to seizures, drastically conﬁning the temporal
window of the detrimental immune hit; this contrasts with
previous studies in which PolyI:C was administered daily dur-
ing pregnancy (44). The neuronal network hyperactivity occurs
in the absence of a classic inﬂammatory response in the
offspring. Also, we did not ﬁnd signiﬁcant alterations in syn-
apse pattern or spontaneous neurotransmission in offspring
brain slices.
Which, then, is the molecular mechanism responsible for the
network hyperexcitability in prenatally challenged mice? Our
data indicate that MIA delays the normal developmental
expression of KCC2, resulting in persistence of higher intra-
cellular chloride concentrations and delayed GABA switch.
Our study also unveils a molecular trajectory activated by
MIA—i.e., the enhanced binding of the two repressors REST
(also known as neuron-restrictive silencer factor) and methyl-
CpG-binding protein 2 to the 509 site of the Kcc2 promoter,
which leads to reduced Kcc2 transcription (36,45). Although
NKCC1 expression is also altered, and higher levels wereurnal
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with controls, mRNA levels were not changed. Therefore, the
reciprocal regulation of the two transporters is impaired at the
transcriptional level for KCC2 and at the posttranslational level
for NKCC1. Because of this imbalance, intracellular chloride
concentrations aremore elevated in PolyI:C offspring brain, and
GABA persists in being excitatory at developmental time win-
dows when it is normally inhibitory. This process renders
neuronal networks hyperexcitable and susceptible to seizures
triggered by excitatory stimuli. Genetic alterations in the KCC2
gene have been reported to confer increased seizure suscep-
tibility (46–51), but this is the ﬁrst demonstration that an envi-
ronmental stimulus can modify KCC2 expression and lead to an
epileptic phenotype. Of note, a defect in depolarizing to
hyperpolarizing switch, responsible for an excitatory/inhibitory
imbalance, has been identiﬁed as a key pathophysiological
mechanism not only in epilepsy but also in neurodevelopmental
disorders, such as autism (52,53), which are typically associated
with MIA and for which a mechanistic frame is still completely
lacking. Consistent with a role for epigenetic mechanisms in
changing the neuron developmental trajectories, the delay in
excitatory-to-inhibitory switch is intrinsically maintained in
neurons isolated from the brain and maintained in primary cul-
tures, independently of the brain environment. This is consistent
with behavioral alterations caused by MIA occurring in the ﬁrst-
and second-generation offspring of immune-challenged an-
cestors, demonstrating the transgenerational nongenetic in-
heritance of pathological traits (17).
We did not detect alterations in the activation proﬁle of
microglia in the adult offspring, in line with previous studies
where no overt glial anomalies were detected in mice prena-
tally exposed to PolyI:C at either early or late stages of preg-
nancy (54,55). The transient increase in proinﬂammatory
cytokines occurring in the fetal brain after MIA likely is at the
root of the processes leading to KCC2 dysregulation. Indeed,
normal expression of KCC2 in the offspring can be restored by
genetic (IL-1RI KO) or pharmacological (MgSO4) approaches
able to prevent the transient increase in IL-6 and IL-1b in the
fetal brain. Although we are presently unable to selectively
pinpoint which one of the two cytokines—which are potently
cross-regulated—may be directly responsible for the defective
excitatory-to-inhibitory switch, it is notable that IL-1b is per se
sufﬁcient to alter chloride concentrations when applied to
primary neuronal cultures, suggesting that this cytokine may
be at the root of the process. It was recently suggested that
immune signaling in neurons may converge upon mammalian
target of rapamycin, which acts as a regulatory hub integrating
inputs from numerous upstream intracellular signalling path-
ways, many of which are altered in the brains of immune-
challenged offspring (4). Consistently, IL-1b impinges on the
mammalian target of rapamycin/protein kinase B pathway,
eventually impacting brain plasticity processes (56). Of note, a
selective increase of IL-1b levels was detected in the hippo-
campi of GD9 PolyI:C-treated offspring, further pointing to a
crucial role of this cytokine (55).
We ﬁnally suggest a translational exploitation of our ﬁndings
that might be particularly proﬁtable given the association be-
tween maternal infection during pregnancy and childhood
epilepsy (57). MgSO4, which has been previously shown to
decrease the inﬂammatory cytokine production from immuneBiologicalcells (42), is able to fully prevent the increase of IL-6 and IL-1b
in the brain of prenatally exposed mice, similar to what occurs
in IL-1RI KO embryos. As a result, upon treatment of pregnant
dams with MgSO4, PolyI:C completely fails in causing KCC2
alterations and enhanced susceptibility to seizures. MgSO4
can therefore be an early and relatively safe prevention treat-
ment to avoid the long-term consequences of prenatal in-
fections. Although magnesium is already used in clinics to
reduce inﬂammation at the maternal–fetal interface under
speciﬁc pathological conditions (43), the protocols for the use
of MgSO4 remain controversial. Aside from ideal dosing and
timing remaining unclear, “the different gestational ages at
randomization leave clinicians confused about which patients
should be candidates for neuroprotection” (58). Our data
clearly indicate a key time window (the end of the ﬁrst trimester
of pregnancy, i.e., the beginning of cortical layering) in which
maternal treatment with MgSO4 may be decisive for preventing
disturbances to one of the most relevant neurodevelopmental
mechanisms, the GABA developmental switch. In this frame,
MgSO4 may be proposed as a safe therapeutic intervention to
decrease the incidence of immune-mediated neurological or
psychiatric illness in adulthood caused by maternal viral
infections at the end of the ﬁrst trimester of pregnancy.
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